Detalhe da pesquisa
1.
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity.
Ann Surg Oncol
; 29(4): 2456-2468, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35129721
2.
Usefulness of an immunohistochemical score in advanced pancreatic neuroendocrine tumors treated with CAPTEM or everolimus.
Pancreatology
; 21(1): 215-223, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33358592
3.
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
Br J Cancer
; 122(4): 498-505, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857726
4.
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
Ann Surg Oncol
; 22(7): 2352-8, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25564157
5.
PAK1 mediates pancreatic cancer cell migration and resistance to MET inhibition.
J Pathol
; 234(4): 502-13, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25074413
6.
The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy.
HPB (Oxford)
; 17(4): 292-8, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25250696
7.
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.
Invest New Drugs
; 32(4): 739-45, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24668033
8.
Baseline hemoglobin-A1c impacts clinical outcomes in patients with pancreatic cancer.
J Natl Compr Canc Netw
; 12(1): 50-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24453292
9.
Molecular Characterization and Treatment of Pancreatic Neuroendocrine Tumors.
Oncology (Williston Park)
; 33(12)2019 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31914198
10.
Germline Testing identifies Pathogenic/Likely Pathogenic Variants in Patients with Pancreatic Neuroendocrine Tumors.
Cancer Prev Res (Phila)
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662083
11.
Clinical outcomes of liposomal irinotecan in advanced pancreatic adenocarcinoma patients previously treated with conventional irinotecan-based chemotherapy: a real-world study.
Front Oncol
; 13: 1250136, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37700832
12.
Gemcitabine, Docetaxel, Capecitabine, Cisplatin, Irinotecan as First-line Treatment for Metastatic Pancreatic Cancer.
Cancer Res Commun
; 3(8): 1672-1677, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37645623
13.
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
Nat Commun
; 14(1): 3650, 2023 06 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339979
14.
Genetics of Pancreatic Neuroendocrine Tumors.
Hematol Oncol Clin North Am
; 36(5): 1033-1051, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36154786
15.
The Evolving Paradigm of Germline Testing in Pancreatic Ductal Adenocarcinoma and Implications for Clinical Practice.
Surg Pathol Clin
; 15(3): 491-502, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-36049831
16.
Pembrolizumab in Patients With Microsatellite Instability-High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study.
J Clin Oncol
; 40(7): 752-761, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34990208
17.
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer.
Curr Oncol
; 30(1): 75-84, 2022 12 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36661655
18.
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal Adenocarcinoma.
Cancer Res Commun
; 2(11): 1418-1425, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36970054
19.
High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapy.
Cancer Med
; 11(7): 1659-1668, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35142085
20.
Health-related quality of life in patients treated with pembrolizumab for microsatellite instability-high/mismatch repair-deficient advanced solid tumours: Results from the KEYNOTE-158 study.
Eur J Cancer
; 169: 188-197, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35588692